The role of iNKT cells in the immunopathology of systemic lupus erythematosus.

L Gabriel, Bernard J Morley, NJ Rogers

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

An increasing body of evidence suggests that CD1d-restricted invariant natural killer T (iNKT) cells play an important immunoregulatory role in a variety of autoimmune diseases in both humans and mouse models. Their role in systemic lupus erythematosus (SLE), however, is not fully determined, as SLE mouse models have yielded conflicting results demonstrating both a protective function and a pathogenic role. The reduced frequency of iNKT cells in peripheral blood of lupus patients supports the idea of a protective role for these cells in the immunopathology of SLE. Therapeutic approaches using glycolipids provide a promising tool to correct numerical iNKT cell deficiencies and to modulate their function. This review highlights the potential role of iNKT cells in lupus immunopathology and summarizes recent studies concerning iNKT cells in SLE patients, lupus-prone murine models and glycolipid therapy.
Original languageEnglish
Pages (from-to)435-441
Number of pages7
JournalAnnals of the New York Academy of Sciences
Volume1173
Issue numberContemporary Challenges in Autoimmunity
DOIs
Publication statusPublished - Sep 2009

Fingerprint

Natural Killer T-Cells
T-cells
Systemic Lupus Erythematosus
Glycolipids
Autoimmune Diseases
Blood
Cells
Therapeutics

Keywords

  • regulatory T cells
  • systemic lupus erythematosus
  • iNKT cells
  • autoimmunity

Cite this

The role of iNKT cells in the immunopathology of systemic lupus erythematosus. / Gabriel, L; Morley, Bernard J; Rogers, NJ.

In: Annals of the New York Academy of Sciences, Vol. 1173, No. Contemporary Challenges in Autoimmunity, 09.2009, p. 435-441.

Research output: Contribution to journalArticle

Gabriel, L ; Morley, Bernard J ; Rogers, NJ. / The role of iNKT cells in the immunopathology of systemic lupus erythematosus. In: Annals of the New York Academy of Sciences. 2009 ; Vol. 1173, No. Contemporary Challenges in Autoimmunity. pp. 435-441.
@article{3453be14e78a4213bf558149c1c42eae,
title = "The role of iNKT cells in the immunopathology of systemic lupus erythematosus.",
abstract = "An increasing body of evidence suggests that CD1d-restricted invariant natural killer T (iNKT) cells play an important immunoregulatory role in a variety of autoimmune diseases in both humans and mouse models. Their role in systemic lupus erythematosus (SLE), however, is not fully determined, as SLE mouse models have yielded conflicting results demonstrating both a protective function and a pathogenic role. The reduced frequency of iNKT cells in peripheral blood of lupus patients supports the idea of a protective role for these cells in the immunopathology of SLE. Therapeutic approaches using glycolipids provide a promising tool to correct numerical iNKT cell deficiencies and to modulate their function. This review highlights the potential role of iNKT cells in lupus immunopathology and summarizes recent studies concerning iNKT cells in SLE patients, lupus-prone murine models and glycolipid therapy.",
keywords = "regulatory T cells, systemic lupus erythematosus, iNKT cells, autoimmunity",
author = "L Gabriel and Morley, {Bernard J} and NJ Rogers",
year = "2009",
month = "9",
doi = "10.1111/j.1749-6632.2009.04743.x",
language = "English",
volume = "1173",
pages = "435--441",
journal = "Annals of the New York Academy of Sciences",
issn = "0077-8923",
publisher = "Wiley-Blackwell",
number = "Contemporary Challenges in Autoimmunity",

}

TY - JOUR

T1 - The role of iNKT cells in the immunopathology of systemic lupus erythematosus.

AU - Gabriel, L

AU - Morley, Bernard J

AU - Rogers, NJ

PY - 2009/9

Y1 - 2009/9

N2 - An increasing body of evidence suggests that CD1d-restricted invariant natural killer T (iNKT) cells play an important immunoregulatory role in a variety of autoimmune diseases in both humans and mouse models. Their role in systemic lupus erythematosus (SLE), however, is not fully determined, as SLE mouse models have yielded conflicting results demonstrating both a protective function and a pathogenic role. The reduced frequency of iNKT cells in peripheral blood of lupus patients supports the idea of a protective role for these cells in the immunopathology of SLE. Therapeutic approaches using glycolipids provide a promising tool to correct numerical iNKT cell deficiencies and to modulate their function. This review highlights the potential role of iNKT cells in lupus immunopathology and summarizes recent studies concerning iNKT cells in SLE patients, lupus-prone murine models and glycolipid therapy.

AB - An increasing body of evidence suggests that CD1d-restricted invariant natural killer T (iNKT) cells play an important immunoregulatory role in a variety of autoimmune diseases in both humans and mouse models. Their role in systemic lupus erythematosus (SLE), however, is not fully determined, as SLE mouse models have yielded conflicting results demonstrating both a protective function and a pathogenic role. The reduced frequency of iNKT cells in peripheral blood of lupus patients supports the idea of a protective role for these cells in the immunopathology of SLE. Therapeutic approaches using glycolipids provide a promising tool to correct numerical iNKT cell deficiencies and to modulate their function. This review highlights the potential role of iNKT cells in lupus immunopathology and summarizes recent studies concerning iNKT cells in SLE patients, lupus-prone murine models and glycolipid therapy.

KW - regulatory T cells

KW - systemic lupus erythematosus

KW - iNKT cells

KW - autoimmunity

UR - http://www.scopus.com/inward/record.url?scp=70049094992&partnerID=8YFLogxK

UR - http://dx.doi.org/10.1111/j.1749-6632.2009.04743.x

U2 - 10.1111/j.1749-6632.2009.04743.x

DO - 10.1111/j.1749-6632.2009.04743.x

M3 - Article

VL - 1173

SP - 435

EP - 441

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

SN - 0077-8923

IS - Contemporary Challenges in Autoimmunity

ER -